𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Everolimusvs.rapamycin for treating diabetic nephropathy in diabetic mouse model

✍ Scribed by Lan Cheng; Jingli Chen; Xiaolu Mao

Book ID
107408208
Publisher
Springer-Verlag
Year
2011
Tongue
Chinese
Weight
461 KB
Volume
31
Category
Article
ISSN
0510-9752

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A model for diabetic nephropathy: Advant
A model for diabetic nephropathy: Advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse
✍ Akari Inada; Hiroshi Kanamori; Hidenori Arai; Tomoyuki Akashi; Makoto Araki; Gor πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 651 KB

## Abstract We have previously found progressive diabetic nephropathy in inducible cAMP early repressor (ICER IΞ³) transgenic (Tg) mice. The ICER IΞ³ Tg mouse is an interesting model of sustained hyperglycemia due to its low production of insulin and insulin‐producing Ξ² cells. Here in a longitudinal

Considerations for treating dyslipidemia
Considerations for treating dyslipidemia in special diabetic populations
✍ Anne Peters Harmel πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 84 KB

## Abstract This is a review of the problem of dyslipidemia and cardiovascular disease (CVD) in special diabetic populations. Clearly all patients with diabetes are at increased risk for CVD compared to non‐diabetic populations. But within the subset that is patients with diabetes there are individ